Rong-Rong Zhang, Yong-Yi Yang, Man Wang, Wen-Ru Yang, Riaz Muhammad Azeem, Fu-Xuan Niu, Ya-Xin Yang, Man-Jie Hu, Chun-Wei Shi, Gui-Lian Yang, Hai-Bin Huang, Jian-Zhong Wang, Yan-Long Jiang, Xin Cao, Nan Wang, Yan Zeng, Wen-Tao Yang, Chun-Feng Wang
{"title":"Rotavirus induces mucosal B-cell responses through the TLR3/TRIF and MAVS pathways","authors":"Rong-Rong Zhang, Yong-Yi Yang, Man Wang, Wen-Ru Yang, Riaz Muhammad Azeem, Fu-Xuan Niu, Ya-Xin Yang, Man-Jie Hu, Chun-Wei Shi, Gui-Lian Yang, Hai-Bin Huang, Jian-Zhong Wang, Yan-Long Jiang, Xin Cao, Nan Wang, Yan Zeng, Wen-Tao Yang, Chun-Feng Wang","doi":"10.1016/j.vetmic.2026.110910","DOIUrl":null,"url":null,"abstract":"<div><div>Rotavirus (RV) infection is a zoonotic disease that causes severe diarrhea in young mammals and humans and is spreading globally. The TLR3/TRIF and RIG-I/MAVS signaling pathways are activated upon recognition of double-stranded RNA (dsRNA) and play crucial roles in the host antiviral response during RV infection. However, the mechanism by which RV induces B-cell immune responses through TLR3 and RIG-I signaling remains unclear. Here, T-cell receptor (TCR) sequencing results revealed that TRIF gene deletion affects the frequency of complementarity-determining region 3 (CDR3) clones recognizing antigen peptides presented by MHC-II on B cells and the utilization of V and J genes in mouse CD4<sup>+</sup> T cells. Specifically, a reduced frequency of germinal center (GC)-activated B cells was observed in the mesenteric lymph nodes (MLNs) of TLR3<sup>-/-</sup>, TRIF<sup>-/-</sup>, and MAVS<sup>-/-</sup> mice. Similarly, the levels of antibodies secreted by B cells in serum and CD138<sup>+</sup>IgA<sup>+</sup> cells in the small intestine decreased. The simultaneous absence of the TLR3 and MAVS genes weakened the proliferative capacity of B cells. This study elucidates the mechanism by which RV regulates B-cell immunity through the TLR3/TRIF and MAVS signaling pathways, providing theoretical basis for novel vaccine development.</div></div>","PeriodicalId":23551,"journal":{"name":"Veterinary microbiology","volume":"314 ","pages":"Article 110910"},"PeriodicalIF":2.8000,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Veterinary microbiology","FirstCategoryId":"97","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0378113526000416","RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/30 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Rotavirus (RV) infection is a zoonotic disease that causes severe diarrhea in young mammals and humans and is spreading globally. The TLR3/TRIF and RIG-I/MAVS signaling pathways are activated upon recognition of double-stranded RNA (dsRNA) and play crucial roles in the host antiviral response during RV infection. However, the mechanism by which RV induces B-cell immune responses through TLR3 and RIG-I signaling remains unclear. Here, T-cell receptor (TCR) sequencing results revealed that TRIF gene deletion affects the frequency of complementarity-determining region 3 (CDR3) clones recognizing antigen peptides presented by MHC-II on B cells and the utilization of V and J genes in mouse CD4+ T cells. Specifically, a reduced frequency of germinal center (GC)-activated B cells was observed in the mesenteric lymph nodes (MLNs) of TLR3-/-, TRIF-/-, and MAVS-/- mice. Similarly, the levels of antibodies secreted by B cells in serum and CD138+IgA+ cells in the small intestine decreased. The simultaneous absence of the TLR3 and MAVS genes weakened the proliferative capacity of B cells. This study elucidates the mechanism by which RV regulates B-cell immunity through the TLR3/TRIF and MAVS signaling pathways, providing theoretical basis for novel vaccine development.
期刊介绍:
Veterinary Microbiology is concerned with microbial (bacterial, fungal, viral) diseases of domesticated vertebrate animals (livestock, companion animals, fur-bearing animals, game, poultry, fish) that supply food, other useful products or companionship. In addition, Microbial diseases of wild animals living in captivity, or as members of the feral fauna will also be considered if the infections are of interest because of their interrelation with humans (zoonoses) and/or domestic animals. Studies of antimicrobial resistance are also included, provided that the results represent a substantial advance in knowledge. Authors are strongly encouraged to read - prior to submission - the Editorials (''Scope or cope'' and ''Scope or cope II'') published previously in the journal. The Editors reserve the right to suggest submission to another journal for those papers which they feel would be more appropriate for consideration by that journal.
Original research papers of high quality and novelty on aspects of control, host response, molecular biology, pathogenesis, prevention, and treatment of microbial diseases of animals are published. Papers dealing primarily with immunology, epidemiology, molecular biology and antiviral or microbial agents will only be considered if they demonstrate a clear impact on a disease. Papers focusing solely on diagnostic techniques (such as another PCR protocol or ELISA) will not be published - focus should be on a microorganism and not on a particular technique. Papers only reporting microbial sequences, transcriptomics data, or proteomics data will not be considered unless the results represent a substantial advance in knowledge.
Drug trial papers will be considered if they have general application or significance. Papers on the identification of microorganisms will also be considered, but detailed taxonomic studies do not fall within the scope of the journal. Case reports will not be published, unless they have general application or contain novel aspects. Papers of geographically limited interest, which repeat what had been established elsewhere will not be considered. The readership of the journal is global.